Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
2025;136(4):e70021
82 HP 175 IGF-1 LR3 Long R3 IGF-1 extended half-life anabolic research compound ALIASES Long R3 IGF-1, LR3 IGF-1, IGF-1LR3, IGF1 LR3 CLASS Synthetic 83-residue insulin-like growth factor 1 analog FORMULA C400H625N111O115S9 HALF-LIFE ~6 hours (vs ~10 minutes native IGF-1) ROUTES Subcutaneous (research) MECHANISM OF ACTION Long R3 Insulin-like Growth Factor 1 83-residue synthetic analog of native IGF-1 with N-terminal 13-residue extension and Arg substitution at position 3
Food and Drug Administration (FDA) for injectable preparation guidelines PubMed for peptide stability and reconstitution research World Health Organization (WHO) for safe injection practices CDC Injection Safety for contamination prevention protocols For researchers committed to getting peptide reconstitution right every time, SeekPeptides provides the most comprehensive tools available
Keywords: Hypobaric hypoxia, Hypoxia chamber, PO2, PCO2, Histopathological analysis, Oxidative stress HH: Hypobaric hypoxia
It is identified as one of the most important medications needed in a basic health system
It is most suitable for women who wish to avoid a hysterectomy
US$ 25.55
US$ 23.87
US$ 21.83
US$ 21.35
US$ 22.25
